Breast Cancer

EDU 04 - (INTERACTIVE) Management of the Axilla and Neoadjuvant Systemic Therapy

10/21/2018
4:45 PM - 6:15 PM
Location: Room 214 A/B

Session Type: Educational
1.50 AMA PRA Category 1 Credits™
1.50 CAMPEP Credits
1.50 MDCB Credits

In this session, presenters will discuss the controversies involved in radiotherapy and surgical decision-making in the era of neoadjuvant systemic therapy. Data from randomized trials will be described where available, along with the relevant strengths and limitations. Supplemental data describing factors that modify risk of recurrence and potential radiotherapy impact will also be reviewed, as will ongoing trials that may impact management of this clinical scenario in coming years. Data characterizing the relationship between chemotherapy response and locoregional control will also be reviewed, as will impact on patient long-term morbidity and quality of life. Again, priority will be given to data from randomized and/or prospective trials but other robust series will also be incorporated. The instructors will incorporate case presentations designed to illustrate salient points from the didactic presentations as appropriate.

Learning Objectives:

Presentations:

Rachel Jimenez, MD

Disclosure:
Employment
Massachusetts General Hospital: Employee: Employee

Presentation(s):

Send Email for Rachel Jimenez


Assets

EDU 04 - (INTERACTIVE) Management of the Axilla and Neoadjuvant Systemic Therapy



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for EDU 04 - (INTERACTIVE) Management of the Axilla and Neoadjuvant Systemic Therapy